pI: 6.8208 |
Length (AA): 471 |
MW (Da): 53973 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 2
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_131896)
Species | Accession | Gene Product |
---|---|---|
Babesia bovis | BBOV_III003130 | protein kinase domain containing protein |
Candida albicans | CaO19.8058 | similar to S. cerevisiae IKS1 (YJL057C) kinase suppressor of Ira1 |
Candida albicans | CaO19.428 | similar to S. cerevisiae IKS1 (YJL057C) kinase suppressor of Ira1 |
Cryptosporidium hominis | Chro.70346 | hypothetical protein |
Cryptosporidium parvum | cgd7_3080 | hypothetical protein |
Dictyostelium discoideum | DDB_G0283109 | IKS family protein kinase |
Leishmania braziliensis | LbrM.25.2570 | protein kinase, putative |
Leishmania donovani | LdBPK_251580.1 | protein kinase, putative |
Leishmania infantum | LinJ.25.1580 | protein kinase, putative |
Leishmania major | LmjF.25.1520 | protein kinase, putative |
Leishmania mexicana | LmxM.25.1520 | protein kinase, putative |
Neospora caninum | NCLIV_034010 | Wee kinase, putative |
Saccharomyces cerevisiae | YJL057C | Iks1p |
Trypanosoma brucei gambiense | Tbg972.3.1350 | protein kinase, putative |
Trypanosoma brucei | Tb927.3.1570 | Lapatinib-binding protein kinase 3 |
Trypanosoma congolense | TcIL3000_0_56770 | protein kinase, putative |
Trypanosoma congolense | TcIL3000_3_660 | protein kinase, putative |
Trypanosoma cruzi | TcCLB.510089.80 | protein kinase, putative |
Trypanosoma cruzi | TcCLB.510421.90 | protein kinase, putative |
Toxoplasma gondii | TGME49_273690 | Wee kinase |
Theileria parva | TP04_0139 | serine/threonine protein kinase, putative |
Trichomonas vaginalis | TVAG_258290 | AGC family protein kinase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.3.1570 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.1570 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.1570 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb927.3.1570 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_273690 | Toxoplasma gondii | Probably non-essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Oryctolagus cuniculus | Cyclin-dependent kinase 4 | 189 aa | 24.0% | 196 aa | Compounds | References |
Xenopus laevis | Aurora kinase B-B | 368 aa | 20.3% | 305 aa | Compounds | References |
Rattus norvegicus | Jak1 protein | 210 aa | 25.5% | 235 aa | Compounds | References |
Patiria pectinifera | Cdc2 | 300 aa | 23.4% | 265 aa | Compounds | References |
Xenopus laevis | Aurora kinase B-A | 361 aa | 20.3% | 305 aa | Compounds | References |
Homo sapiens | Cyclin-dependent kinase 1/cyclin B1 | 297 aa | 25.8% | 256 aa | Compounds | References |
Rattus norvegicus | Cell division protein kinase 5 | 292 aa | 20.2% | 292 aa | Compounds | References |